Pharma Reviews: Cipla may be Re-Rated for Probable Commercial JV with Moderna'mRNA COVID Vaccine

Cipla is a major Indian pharmaceutical company and MNC; almost 60% of its ... as the COVID-19 vaccines, mRNA could transform the drug industry.
Read more: Cipla may be Re-Rated for Probable Commercial JV with Moderna'mRNA COVID Vaccine